Results 141 to 150 of about 174,736 (301)

Risk Factors for Postsurgical Gout Flares after Thoracolumbar Spine Surgeries [PDF]

open access: gold, 2022
Kuan‐Jung Chen   +7 more
openalex   +1 more source

The return of metabolism: biochemistry and physiology of glycolysis

open access: yesBiological Reviews, EarlyView.
ABSTRACT Glycolysis is a fundamental metabolic pathway central to the bioenergetics and physiology of virtually all living organisms. In this comprehensive review, we explore the intricate biochemical principles and evolutionary origins of glycolytic pathways, from the classical Embden–Meyerhof–Parnas (EMP) pathway in humans to various prokaryotic and ...
Nana‐Maria Grüning   +19 more
wiley   +1 more source

Gout Flare Burden in the United States: A Multiyear Cross‐Sectional Survey Study

open access: yesACR Open Rheumatology
Objective The objective of this study was to assess the burden of gout flares and examine associated patient characteristics and outcomes in a sample of US adults.
Jasvinder A. Singh   +2 more
doaj   +1 more source

Gouty Tophi of the Fingertips Induced by Repeated Microtrauma

open access: yes
JEADV Clinical Practice, EarlyView.
A. Gotor‐Rivera   +3 more
wiley   +1 more source

Perioperative Nivolumab in Resectable Non‐Small Cell Lung Cancer: A Subanalysis of Japanese Patients From CheckMate 77T

open access: yesCancer Science, EarlyView.
ABSTRACT In the randomized phase III CheckMate 77T study, perioperative nivolumab showed statistically significant and clinically meaningful improvement in event‐free survival (EFS) vs. placebo in patients with resectable, non‐metastatic non‐small cell lung cancer (NSCLC).
Fumihiro Tanaka   +17 more
wiley   +1 more source

AB1042 PEGLOTICASE USE IN RENAL TRANSPLANT RECIPIENTS WITH GOUT: AN INSURANCE CLAIMS STUDY [PDF]

open access: bronze, 2022
Craig Alan Shadur   +3 more
openalex   +1 more source

Adjuvant therapy of severe and/or refractory bullous pemphigoid with immunoadsorption – A prospective monocenter pilot study

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background and Objectives Bullous pemphigoid (BP) is the most common autoimmune blistering disease in the Western world. While remission is achieved in the majority of BP patients by long‐term use of corticosteroids with or without immunomodulants/immunosuppressants, national and international guidelines recommend adjuvant immunoadsorption (IA)
Maike M. Holtsche   +7 more
wiley   +1 more source

Insight into the Epidemiology and Evolutionary History of Novel Goose Astrovirus-Associated Gout in Goslings in Southern China [PDF]

open access: gold, 2022
Xinliang Fu   +10 more
openalex   +1 more source

Home - About - Disclaimer - Privacy